Skip to main content
ALLERGY THERAPEUTICS PLC logo

ALLERGY THERAPEUTICS PLC — Investor Relations & Filings

Ticker · AGY ISIN · GB00B02LCQ05 LEI · 213800PQ7AHK7KGVOE23 IL Manufacturing
Open in API
Filings indexed 416 across all filing types
Latest filing 2015-11-25 Remuneration Information
Country GB United Kingdom
Listing IL AGY

About ALLERGY THERAPEUTICS PLC

https://allergytherapeutics.com/

Allergy Therapeutics PLC is an immunology company focused on the research, development, diagnosis, and treatment of allergic disorders. The company specializes in creating therapies for allergy treatment and prevention, with a key focus on developing aluminum-free immunotherapies and allergy vaccines. These treatments aim to address the underlying cause of the allergy rather than merely managing symptoms. Leveraging its specialist expertise in immunology, the company strives to develop effective and convenient solutions to improve the quality of life for individuals with allergies.

Recent filings

Filing Released Lang Actions
Grant of Options under Long Term Incentive Plan
Remuneration Information Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states 'This information is provided by RNS The company news service from the London Stock Exchange'. The content details the grant of options (shares) to directors under a Long Term Incentive Plan (LTIP) following the fulfillment of performance conditions. This type of announcement, concerning insider transactions (directors receiving options/shares) and capital structure changes related to employee compensation, is often classified under Director's Dealing (DIRS) or Share Issue/Capital Change (SHA). However, the core event is the granting of options to directors, which falls under insider transactions/director dealings. Since the document is a formal regulatory news service announcement (RNS) detailing director transactions, the most specific fit among the provided options is Director's Dealing (DIRS). If DIRS were not available, RNS would be the fallback, but DIRS is more specific to the content regarding director option grants.
2015-11-25 English
Result of AGM
AGM Information Classification · 100% confidence The document explicitly states it is an announcement regarding the 'Result of Annual General Meeting' and is distributed via 'RNS Number'. The content confirms that 'all the resolutions put to that meeting were duly passed'. This directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, or potentially Declaration of Voting Results & Voting Rights Announcements (DVA). Since it is specifically announcing the *result* of the AGM resolutions, AGM-R is the most precise fit, as DVA is usually for the official results document itself, whereas this is a brief announcement of the outcome, often released immediately following the meeting. Given the context of RNS distribution and the short length (1531 chars), it functions as an immediate update on the AGM proceedings.
2015-11-18 English
Results of Placing
Capital/Financing Update Classification · 98% confidence The document is identified by the RNS Number (0191G) and the date (17 November 2015). The content explicitly announces the 'successful completion of the Placing' to raise £11.5 million through the issuance of 41,005,500 new ordinary shares. This is a direct announcement regarding a fundraising and capital structure change. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). Although it is distributed via RNS, the core subject matter is financing, making CAP the most specific classification. The document length is short (4889 chars), but it is the primary announcement of the financing event, not just an announcement that a report is attached.
2015-11-17 English
Proposed placing to raise up to £12 million
Capital/Financing Update Classification · 98% confidence The document is an RNS announcement dated November 17, 2015, detailing a 'Proposed placing to raise up to £12 million' through the issuance of new ordinary shares. This action directly relates to fundraising, capital structure changes, and the issuance of new shares. This fits the definition of 'Capital/Financing Update' (CAP). Although it involves share issuance (SHA) and is a regulatory filing (RNS), the primary purpose and focus is the capital raise/placing. Since CAP is a more specific category for fundraising activities than SHA (which is broader share changes) or RNS (which is a fallback), CAP is the most appropriate classification. The document length is substantial, so it is not an RPA.
2015-11-17 English
Trading Update
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content is a 'Trading Update' providing sales figures, growth rates, strategic acquisitions (VLP license), and an announcement of a share placing to raise capital. This is a general, timely announcement to the market that does not fit the specific definitions of an Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or a specific capital change (CAP/SHA). Since it is a general regulatory announcement disseminated via the RNS system and covers multiple operational and financial updates, the most appropriate fallback category is Regulatory Filings (RNS). The document length (3847 chars) is short, but it contains substantive updates rather than just announcing another report, making RNS more suitable than RPA.
2015-11-17 English
Group of companies' accounts made up to 2015-06-30
Regulatory Filings
2015-11-06 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.